Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 36.7% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 14,139 shares of the medical research company’s stock after acquiring an additional 3,799 shares during the period. Sumitomo Mitsui […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) General Counsel James Herriott sold 1,300 shares of the stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $100.00, for a total transaction of $130,000.00. Following the completion of the transaction, the general counsel now owns 5,964 […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) General Counsel James Herriott sold 1,300 shares of the business’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $100.00, for a total value of $130,000.00. Following the completion of the transaction, the general counsel now directly […]
Gratus Capital LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 5,000 shares of the medical research company’s stock, valued at approximately $339,000. Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. American […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target raised by Craig Hallum from $85.00 to $106.00 in a research report report published on Thursday, The Fly reports. A number of other analysts have also recently weighed in on the company. Benchmark increased their price target on Exact Sciences from $81.00 to $96.00 in […]